Perico N, Remuzzi G
Mario Negri Institute for Pharmacological Research, Bergamo, Italy.
Am J Kidney Dis. 1993 Sep;22(3):355-66. doi: 10.1016/s0272-6386(12)70137-3.
The nephrotic syndrome is associated with an expanded interstitial volume and edema due to sodium and water retention. The mechanisms underlying these abnormalities have been only partially clarified. Renal hypoperfusion has been considered the key event that promotes avid sodium and water reabsorption by the kidney. Hypoperfusion results from hypovolemia, a consequence of urinary protein losses and decreased oncotic pressure. However, in some patients plasma volume is normal or even increased, suggesting that in such cases the cause of sodium and water retention might be independent of systemic events and possibly originates in the kidney. Experimental evidence is now available to support this, but the intrarenal mediator(s) that promote the abnormal salt retention are still not fully clear. Atrial natriuretic peptide (ANP), which increases sodium and water excretion, has been suspected to participate in fluid retention. This is consistent with experimental and human data of a markedly blunted natriuretic and diuretic response to systemic infusion of ANP in the nephrotic syndrome. Recent studies of the mechanisms of the blunted natriuretic and diuretic response to ANP documented an increased activity of renal sympathetic nerves, but the results are controversial. The altered response to ANP also may be related to a defect in the number and affinity of receptor-binding sites for the peptide. Evidence also is available of a possible defect at the level of intracellular cyclic guanosine monophosphate, the second messenger of ANP. The gene encoding for a cyclophilin-like protein, which is increased in sodium-retaining conditions, is upregulated in the kidneys of nephrotic rats, and the infusion of ANP further increases cyclophilin-like protein mRNA. Thus, multiple factors probably act in concert to induce edema formation in the nephrotic syndrome. In this review we specifically address the tubular insensitivity to the natriuretic and diuretic action of ANP, which could be an important initiating event and could possibly contribute to sustaining the edema.
肾病综合征与由于钠水潴留导致的间质容积扩大和水肿相关。这些异常现象背后的机制仅得到部分阐明。肾灌注不足被认为是促使肾脏强烈重吸收钠和水的关键事件。灌注不足源于血容量减少,这是尿蛋白丢失和血浆胶体渗透压降低的结果。然而,在一些患者中,血浆容量正常甚至增加,这表明在这些情况下,钠水潴留的原因可能独立于全身因素,可能起源于肾脏。现在有实验证据支持这一点,但促进异常钠潴留的肾内介质仍不完全清楚。心房利钠肽(ANP)可增加钠和水的排泄,曾被怀疑参与液体潴留。这与肾病综合征患者对全身输注ANP的利钠和利尿反应明显减弱的实验及人体数据一致。最近关于对ANP利钠和利尿反应减弱机制的研究记录了肾交感神经活性增加,但结果存在争议。对ANP反应改变也可能与该肽受体结合位点数量和亲和力的缺陷有关。也有证据表明在细胞内环磷酸鸟苷(ANP的第二信使)水平可能存在缺陷。在钠潴留状态下增加的一种亲环素样蛋白的编码基因在肾病大鼠肾脏中上调,输注ANP可进一步增加亲环素样蛋白mRNA。因此,多种因素可能共同作用导致肾病综合征中水肿的形成。在本综述中,我们特别探讨了肾小管对ANP利钠和利尿作用的不敏感性,这可能是一个重要的起始事件,可能有助于维持水肿。